Cite
HARVARD Citation
Thaçi, D. et al. (n.d.). Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE). British journal of dermatology. pp. 777-787. [Online].